Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection
- PMID: 21466619
- PMCID: PMC3746062
- DOI: 10.1111/j.1751-7176.2011.00434.x
Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection
Abstract
Up to 75% of adults with diabetes also have hypertension, and patients with hypertension alone often show evidence of insulin resistance. Thus, hypertension and diabetes are common, intertwined conditions that share a significant overlap in underlying risk factors (including ethnicity, familial, dyslipidemia, and lifestyle determinants) and complications. These complications include microvascular and macrovascular disorders. The macrovascular complications, which are well recognized in patients with longstanding diabetes or hypertension, include coronary artery disease, myocardial infarction, stroke, congestive heart failure, and peripheral vascular disease. Although microvascular complications (retinopathy, nephropathy, and neuropathy) are conventionally linked to hyperglycemia, studies have shown that hypertension constitutes an important risk factor, especially for nephropathy. The familial predisposition to diabetes and hypertension appears to be polygenic in origin, which militates against the feasibility of a "gene therapy" approach to the control or prevention of these conditions. On the other hand, the shared lifestyle factors in the etiology of hypertension and diabetes provide ample opportunity for nonpharmacologic intervention. Thus, the initial approach to the management of both diabetes and hypertension must emphasize weight control, physical activity, and dietary modification. Interestingly, lifestyle intervention is remarkably effective in the primary prevention of diabetes and hypertension. These principles also are pertinent to the prevention of downstream macrovascular complications of the two disorders. In addition to lifestyle modification, most patients will require specific medications to achieve national treatment goals for hypertension and diabetes. Management of hyperglycemia, hypertension, dyslipidemia, and the underlying hypercoagulable and proinflammatory states requires the use of multiple medications in combination.
© 2011 Wiley Periodicals, Inc.
Similar articles
-
Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.J Formos Med Assoc. 2012 Nov;111(11):625-36. doi: 10.1016/j.jfma.2012.09.010. Epub 2012 Nov 27. J Formos Med Assoc. 2012. PMID: 23217598
-
Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.Med Care. 2013 Oct;51(10):879-87. doi: 10.1097/MLR.0b013e31829fa8ed. Med Care. 2013. PMID: 23929398
-
Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).Sci Rep. 2017 Oct 18;7(1):13461. doi: 10.1038/s41598-017-13379-z. Sci Rep. 2017. PMID: 29044139 Free PMC article.
-
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2. Cochrane Database Syst Rev. 2014. PMID: 24526393 Free PMC article. Review.
-
A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.Curr Diabetes Rev. 2021;17(4):457-473. doi: 10.2174/1573399816666201103143818. Curr Diabetes Rev. 2021. PMID: 33143626 Review.
Cited by
-
The Prevalence of Internet Use as a Source of Information Among Patients With Hypertension.Cureus. 2024 Jun 19;16(6):e62730. doi: 10.7759/cureus.62730. eCollection 2024 Jun. Cureus. 2024. PMID: 39036272 Free PMC article.
-
Relationship between Prognostic Nutritional Index and Amputation in Patients with Diabetic Foot Ulcer.Diagnostics (Basel). 2024 Mar 29;14(7):738. doi: 10.3390/diagnostics14070738. Diagnostics (Basel). 2024. PMID: 38611651 Free PMC article.
-
Factors influencing medication adherence in co-morbid hypertension and diabetes patients: A scoping review.Explor Res Clin Soc Pharm. 2024 Feb 29;13:100426. doi: 10.1016/j.rcsop.2024.100426. eCollection 2024 Mar. Explor Res Clin Soc Pharm. 2024. PMID: 38455671 Free PMC article. Review.
-
Empowering patients with comorbid diabetes and hypertension through a multi-component intervention of mobile app, health coaching and shared decision-making: Protocol for an effectiveness-implementation of randomised controlled trial.PLoS One. 2024 Feb 26;19(2):e0296338. doi: 10.1371/journal.pone.0296338. eCollection 2024. PLoS One. 2024. PMID: 38408067 Free PMC article.
-
Postprandial Plasma Glucose Measured from Blood Taken between 4 and 7.9 h Is Positively Associated with Mortality from Hypertension and Cardiovascular Disease.J Cardiovasc Dev Dis. 2024 Feb 4;11(2):53. doi: 10.3390/jcdd11020053. J Cardiovasc Dev Dis. 2024. PMID: 38392267 Free PMC article.
References
-
- Centers for Disease Control and Prevention . 2007 National diabetes fact sheet. http://www.cdc.gov/diabetes/pubs/estimates07.htm#8. Accessed November 13, 2010.
-
- Center for Disease Control and Prevention . SEARCH for Diabetes in Youth. http://www.cdc.gov/diabetes/pubs/factsheets/search.htm#3. Accessed November 13, 2010.
-
- Pettitt DJ, Sand MR, Bennett PM, et al. Familial predisposition to renal disease in two generations of Pima Indians with type II (non‐insulin dependent) diabetes mellitus. Diabetologia. 1990;33:438. - PubMed
-
- Mein CA, Caulfield MJ, Dobson RJ, et al. Genetics of essential hypertension. Hum Mol Genet. 2004;13(Spec No 1):R169–R175. - PubMed
-
- Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinosotides, and sodium‐potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med. 1987;316:599. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical